Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Hologic's Enterprise Value is €14,839 Mil.
Hologic's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €830 Mil. Therefore, Hologic's EV-to-FCF for today is 17.88.
The historical rank and industry rank for Hologic's EV-to-FCF or its related term are showing as below:
MIL:1HOLX'
s EV-to-FCF Range Over the Past 10 Years
Min: -498.74 Med: 18.88 Max: 36.3
Current: 17.89
During the past 13 years, the highest EV-to-FCF of Hologic was 36.30. The lowest was -498.74. And the median was 18.88.
MIL:1HOLX's EV-to-FCF is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 23.305
vs MIL:1HOLX: 17.89
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hologic's share price for today is €63.50.
Hologic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.054.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Hologic EV-to-FCF Related Terms
Hologic EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Hologic's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Hologic's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hologic EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hologic's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Hologic's EV-to-FCF falls into.
Hologic's current Enterprise Value is €14,839 Mil.
Hologic's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €830 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hologic (MIL:1HOLX) has a EV-to-FCF of 17.88 as of Jul. 13, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Hologic and its competitors. This is near median its historical median of 18.88.
Is Hologic's EV-to-FCF too high?
Hologic's current EV-to-FCF of 17.88 is near median its 10-year median of 18.88. The Medical Devices & Instruments industry median EV-to-FCF is 23.31. Hologic's value of 17.88 is 23.3% below this industry median. Overall, Hologic has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hologic's EV-to-FCF compare to WST and COO?
Hologic's EV-to-FCF of 17.88 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-FCF is 23.31. Hologic's value of 17.88 is 23.3% below this benchmark. While the company's 10-year median is 18.88 vs. the industry median of 23.31, Hologic has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.31, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hologic's current EV-to-FCF of 17.88 is 23.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Hologic and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hologic's current EV-to-FCF is 17.88, which is near median its own 10-year median of 18.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hologic stock overvalued right now?
Hologic (MIL:1HOLX) has a current EV-to-FCF of 17.88. The stock's GF Value™ is €68.55, compared to a current price of €63.50 — trading 7.4% below its estimated fair value. The current EV-to-FCF is 17.88, which is near median its 10-year median of 18.88 and 23.3% below the Medical Devices & Instruments industry median of 23.31. Hologic's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Hologic (MIL:1HOLX), the current EV-to-FCF is 17.88 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hologic (MIL:1HOLX) Overvalued in 2026?
Based on GuruFocus' analysis, Hologic stock appears to be undervalued.
The current stock price of €63.50 is trading 7.4% below its estimated GF Value™ of €68.55.
Key valuation signals for MIL:1HOLX:
EV-to-FCF: 17.88 (near median its 10-year median of 18.88)
GF Value™: €68.55 vs. price of €63.50 (7.4% below fair value)
Industry Position: 23.3% below the Medical Devices & Instruments median
No single metric tells the full story. See the MIL:1HOLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
57GF Score
Get the complete analysis for MIL:1HOLX
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1HOLX has been successfully added to your 
